The Effects of Two Polymorphisms on p21cip1 Function and Their Association with Alzheimer’s Disease in a Population of European Descent
Open accessThe DOI matches its Crossref record; 76 of the 78 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
With the exception of ApoE4, genome-wide association studies have failed to identify strong genetic risk factors for late-onset Alzheimer's disease, despite strong evidence of heritability, suggesting that many low penetrance genes may be involved. Additionally, the nature of the identified genetic risk factors and their relation to disease pathology is also largely obscure. Previous studies have found that a cancer-associated variant of the cell cycle inhibitor gene p21cip1 is associated with increased risk of Alzheimer's disease. The aim of this study was to confirm this association and to elucidate the effects of the variant on protein function and Alzheimer-type pathology. We examined the association of the p21cip1 variant with Alzheimer's disease and Parkinson's disease with dementia. The genotyping studies were performed on 719 participants of the Oxford Project to Investigate Memory and Ageing, 225 participants of a Parkinson's disease DNA bank, and 477 participants of the Human Random Control collection available from the European Collection of Cell Cultures. The post mortem studies were carried out on 190 participants. In the in-vitro study, human embryonic kidney cells were transfected with either the common or rare p21cip1 variant; and cytometry was used to assess cell cycle kinetics, p21cip1 protein expression and sub-cellular localisation. The variant was associated with an increased risk of Alzheimer's disease, and Parkinson's disease with dementia, relative to age matched controls. Furthermore, the variant was associated with an earlier age of onset of Alzheimer's disease, and a more severe phenotype, with a primary influence on the accumulation of tangle pathology. In the in-vitro study, we found that the SNPs reduced the cell cycle inhibitory and anti-apoptotic activity of p21cip1. The results suggest that the cancer-associated variant of p21cip1 may contribute to the loss of cell cycle control in neurons that may lead to Alzheimer-type neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“increased oxidative stress, which is already present in the very early stage of the disease and precedes the major pathologic hallmarks, such as senile plaques and neurofibrillary tangles [132,193].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [193]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 9×
“Pre-clinical: Entorhinal stage Alzheimer’s disease (Braak I and II); Mild AD: Limbic stage Alzheimer’s disease (Braak III and IV); Advanced AD: Neocortical stage Alzheimer’s disease (Braak V and VI).”
MethodInfluentialHughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378 · cited 1×
“The diagnosis of PD was made using the UK Parkinson’s Disease Society Brain Bank criteria [42].”
MethodMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 1×
“The information available included the pathological diagnosis (CERAD protocol) [44] and the severity of AD as defined by Braak [45].”
MethodHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Self-citationBallard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Self-citationNaj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901
Role of Genes and Environments for Explaining Alzheimer Disease
Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798 · cited 1×
“Whilst the heritability of AD is up to 80% [2], so far, only one genetic risk factor, the E4 variant of the Apolipoprotein E gene (ApoE), is consistently shown to be associated with an increased risk and reduced age of onset.”
BackgroundGenome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219
CDK inhibitors: Cell cycle regulators and beyond
Besson, A., Dowdy, S. F., & Roberts, J. M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.013 · Cited by 1,152 · cited 2×
“Discussion The CDK inhibitor: p21 is capable of inducing cell cycle arrest at the G1/S and G2/M checkpoints [59].”
BackgroundResultEvolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams-Gray, C. H., Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 934 · cited 1×
“Dementia in PD patients (PDGEN cohort) was established based on the presence of progressive deterioration in intellectual abilities that interferes with activities of daily living [43].”
HEK293 cell line: A vehicle for the expression of recombinant proteins
Thomas, P., & Smart, T. G. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2004.08.014 · Cited by 771 · cited 1×
“The cell line is capable of generating functional, mature proteins and is widely used for the biochemical/cell biological evaluation of expressed proteins in concert with functional analyses to establish pharmacological effects [54].”
BackgroundAltered expression of synaptic proteins occurs early during progression of Alzheimer's disease
Masliah, E., Mallory, M., Alford, M., DeTeresa, R., Hansen, L. A., McKeel, D. W., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.1.127 · Cited by 720
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608
Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation
Asada, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1223 · Cited by 586 · cited 1×
“The subcellular localisation of p21 may dictate its function: with a nuclear location required for its cell cycle regulatory role, and a cytoplasmic location required for its anti-apoptotic role [62,63].”
BackgroundLewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Compta, Y., Parkkinen, L., O'Sullivan, S. S., Vandrovcova, J., Holton, J. L., Collins, C., Lashley, T., Kallis, C., Williams, D. R., de Silva, R., et al. (2011) · Brain · doi:10.1093/brain/awr031 · Cited by 583
Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
Chen, J., Jackson, P. K., Kirschner, M. W., & Dutta, A. (1995) · Nature · doi:10.1038/374386a0 · Cited by 548 · cited 1×
“P21 has a number of additional cellular functions, such as DNA replication and repair [60] and the prevention of apoptosis [61].”
BackgroundBertram, L., Lange, C., Mullin, K., Parkinson, M., Hsiao, M., Hogan, M. F., Schjeide, B. M. M., Hooli, B., DiVito, J., Ionita, I., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.10.008 · Cited by 511
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease
Li, H., Wetten, S., Li, L., St. Jean, P. L., Upmanyu, R., Surh, L., Hosford, D., Barnes, M. R., Briley, J. D., Borrie, M., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.3 · Cited by 499
GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers
Reiman, E. M., Webster, J. A., Myers, A. J., Hardy, J., Dunckley, T., Zismann, V. L., Joshipura, K. D., Pearson, J. V., Hu-Lince, D., Huentelman, M. J., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.022 · Cited by 487
Chang, B.-D., Watanabe, K., Broude, E. V., Fang, J., Poole, J. C., Kalinichenko, T. V., & Roninson, I. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4291 · Cited by 432 · cited 2×
“Cell Culture and Transfection The prolonged consistent overexpression of p21 leads to a complete cessation of cell division [53] and would prevent the detection of subtle effects on cell cycle regulation or apoptosis.”
BackgroundResultActin Dynamics at the Leading Edge: From Simple Machinery to Complex Networks
Insall, R. H., & Machesky, L. M. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.08.012 · Cited by 428 · cited 1×
“Beta-actin is an integral component of the cellular cytoskeleton, which is extensively re-organised during the cell cycle and is upregulated during cellular differentiation [64,65].”
BackgroundExamination of the expanding pathways for the regulation of p21 expression and activity
Jung, Y.-S., Qian, Y., & Chen, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.01.013 · Cited by 423
Neuropathological assessment of the lesions of significance in vascular dementia
Esiri, M. M., Wilcock, G. K., & Morris, J. H. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.6.749 · Cited by 347
Self-citationGenetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer’s disease
Carrasquillo, M. M., Zou, F., Pankratz, V. S., Wilcox, S. L., Ma, L., Walker, L. P., Younkin, S. G., Younkin, C. S., Younkin, L. H., Bisceglio, G. D., et al. (2009) · Nature Genetics · doi:10.1038/ng.305 · Cited by 296
Grupe, A., Abraham, R., Li, Y., Rowland, C., Hollingworth, P., Morgan, A., Jehu, L., Segurado, R., Stone, D., Schadt, E., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm031 · Cited by 289
Actin cytoskeleton dynamics and the cell division cycle
Heng, Y.-W., & Koh, C.-G. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.04.007 · Cited by 283 · cited 1×
“Beta-actin is an integral component of the cellular cytoskeleton, which is extensively re-organised during the cell cycle and is upregulated during cellular differentiation [64,65].”
BackgroundPrevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
Jellinger, K. A., & Attems, J. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0347-5 · Cited by 268 · cited 1×
“Since dementia is mostly attributed to the appearance of AD-type pathology in PD patients [71,72], it is not surprising that the relative frequency of the variant allele and the associated odds ratios are very similar in the AD and PD with dementia groups.”
ResultHuppert, F. A., Brayne, C., Gill, C., Paykel, E. S., & Beardsall, L. (1995) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1995.tb01487.x · Cited by 262 · cited 1×
“The clinical information provided by the OPTIMA team included: age of onset of dementia; age at death; and the results of annual cognitive performance tests (CAMCOG) [40].”
MethodResults of a high-resolution genome screen of 437 Alzheimer's Disease families
Blacker, D. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg007 · Cited by 262
Genome-wide Association Study Implicates a Chromosome 12 Risk Locus for Late-Onset Alzheimer Disease
Beecham, G. W., Martin, E. R., Li, Y.-J., Slifer, M. A., Gilbert, J. R., Haines, J. L., & Pericak-Vance, M. A. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.12.008 · Cited by 260
Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimerʼs disease
Lars Rödel, T. A., Gärtner, U., & Holzer, M. (1996) · NeuroReport · doi:10.1097/00001756-199611250-00050 · Cited by 250 · cited 1×
“The fact that p21 protein expression was only related to tangles, but not to the p21 mRNA or to the amyloid component of the pathology, would suggest that the p21 protein may bind non-specifically to tangles as previously described [39,67,68].”
ResultNagy, Z. S., Esiri, M. M., Jobst, K. A., Johnston, C., Litchfield, S., Sim, E., & Smith, A. D. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00331-c · Cited by 250 · cited 1×
“Historically, the ApoE4 risk factor has been associated with a significantly more severe ADtype pathology in post mortem series [75,76].”
BackgroundSelf-citationA non-enzymatic p21 protein inhibitor of stress-activated protein kinases
Shim, J., Lee, H., Park, J., Kim, H., & Choi, E.-J. (1996) · Nature · doi:10.1038/381804a0 · Cited by 236 · cited 1×
“P21 has a number of additional cellular functions, such as DNA replication and repair [60] and the prevention of apoptosis [61].”
BackgroundThe Effects of Additional Pathology on the Cognitive Deficit in Alzheimer Disease
NAGY, Z., ESIRI, M. M., JOBST, K. A., MORRIS, J. H., -F. KING, E. M., MCDONALD, B., JOACHIM, C., LITCHFIELD, S., BARNETSON, L., & SMITH, A. D. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199702000-00007 · Cited by 218
Self-citationA genome-wide association study for late-onset Alzheimer's disease using DNA pooling
Abraham, R., Moskvina, V., Sims, R., Hollingworth, P., Morgan, A., Georgieva, L., Dowzell, K., Cichon, S., Hillmer, A. M., O'Donovan, M. C., et al. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-44 · Cited by 195
Arendt, T. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.007 · Cited by 188
Control of E2F activity by p21Waf1/Cip1
Delavaine, L., & Thangue, N. B. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202923 · Cited by 188 · cited 3×
“It suppresses E2Fdependent transcription of cell cycle proteins by binding to E2F transcription factor 1 (E2F1) [27].”
BackgroundChild, E. S., & Mann, D. J. (2006) · Cell Cycle · doi:10.4161/cc.5.12.2863 · Cited by 184 · cited 13×
“Whilst we cannot draw conclusions on the individual effects of the p21cip1 SNPs, it is known that the SNP at codon 31 of p21cip1 induces an amino acid change within the binding domain of WISp39, ASK1, procaspase 3, SAPK, TSG101 and E2F-1 [33].”
BackgroundInfluentialCell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression
Bates, S., Ryan, K. M., Phillips, A. C., & Vousden, K. H. (1998) · Oncogene · doi:10.1038/sj.onc.1202104 · Cited by 176
Clare, R., King, V. G., Wirenfeldt, M., & Vinters, H. V. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22392 · Cited by 163
Crean, S., Ward, A., Mercaldi, C. J., Collins, J. M., Cook, M. N., Baker, N. L., & Arrighi, H. M. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000321984 · Cited by 163
Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease
Arendt, T., Holzer, M., & Gärtner, U. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050104 · Cited by 137 · cited 1×
“The fact that p21 protein expression was only related to tangles, but not to the p21 mRNA or to the amyloid component of the pathology, would suggest that the p21 protein may bind non-specifically to tangles as previously described [39,67,68].”
ResultTwo variants of the CIP1/WAF1 gene occur together and are associated with human cancer
Mousses, S., Özçelik, H., D.Lee, P., Malkin, D. M., Bull, S. B., & Andrulis, I. L. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.6.1089 · Cited by 109 · cited 3×
“The single nucleotide polymorphisms (SNPs) are only associated with cancer when they occur together [19,21].”
BackgroundThe neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease
Currais, A., Hortobágyi, T., & Soriano, S. (2009) · Aging · doi:10.18632/aging.100045 · Cited by 101 · cited 1×
“The relationship between an earlier age of onset and more severe tangle pathology and the functionally defective p21 variant supports the hypothesis that the p21 variant, by contributing to the loss of cell cycle control in neurons, is directly involved in the pathogenesis of AD [38,39].”
BackgroundGenome-wide linkage disequilibrium mapping of late-onset Alzheimer’s disease in Finland
Hiltunen, M., Mannermaa, A., Thompson, D., Easton, D., Pirskanen, M., Helisalmi, S., Koivisto, A. M., Lehtovirta, M., Ryynänen, M., & Soininen, H. (2001) · Neurology · doi:10.1212/wnl.57.9.1663 · Cited by 99
Chedid, M., Michieli, P., Lengel, C. R., Huppi, K. E., & Givol, D. (1994) · PubMed · Cited by 95
Expression of apoptosis related proteins in brains of patients with Alzheimer's disease
Engidawork, E., Gulesserian, T., Seidl, R., Cairns, N., & Lubec, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01618-4 · Cited by 91 · cited 1×
“The subcellular localisation of p21 may dictate its function: with a nuclear location required for its cell cycle regulatory role, and a cytoplasmic location required for its anti-apoptotic role [62,63].”
BackgroundFacher, E. A., Becich, M. J., Deka, A., & Law, J. C. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2424::aid-cncr19>3.0.co;2-t · Cited by 88 · cited 4×
“The single nucleotide polymorphisms (SNPs) are only associated with cancer when they occur together [19,21].”
BackgroundMethodInfluentialWhich Vascular Lesions Are of Importance in Vascular Dementia?
Esiri, M. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06373.x · Cited by 78
Self-citationHolmans, P., Hamshere, M. L., Hollingworth, P., Rice, F. J., Tunstall, N., Jones, S., Moore, P. J., DeVriéze, F. W., Myers, A., Crook, R., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30114 · Cited by 74
Bahl, R., Arora, S., Nath, N., Mathur, M., Shukla, N. K., & Ralhan, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203325 · Cited by 69
Association between the p21 Codon 31 A1 (arg) Allele and Lung Cancer
lander, A. S. A., Birgander, R., Rannug, A., Alexandrie, A.-K., Tornling, G., & Beckman, G. (1996) · Human Heredity · doi:10.1159/000154357 · Cited by 63
Jaluria, P., Betenbaugh, M., Konstantopoulos, K., & Shiloach, J. (2007) · BMC Biotechnology · doi:10.1186/1472-6750-7-71 · Cited by 58 · cited 2×
“Transfection efficiency was calculated using the assumption that p21 transfected cells stop proliferating while the non-transfected cells proliferate at their original proliferation rate of ~1 population doubling in 36 hours [55].”
BackgroundMethodAn evaluation of the impact ofMAPT,SNCAandAPOEon the burden of Alzheimer's and Lewy body pathology
Wider, C. W., Ross, O. A., Nishioka, K., Heckman, M. G., Vilariño‐Güell, C., Jasińska‐Myga, B., Erketin-Taner, N., Rademakers, R., Graff‐Radford, N. R., Mash, D. C., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301413 · Cited by 57 · cited 1×
“Historically, the ApoE4 risk factor has been associated with a significantly more severe ADtype pathology in post mortem series [75,76].”
BackgroundThe last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease
Nagy, Z. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00485.x · Cited by 56 · cited 2×
“The fact that p21 protein expression was only related to tangles, but not to the p21 mRNA or to the amyloid component of the pathology, would suggest that the p21 protein may bind non-specifically to tangles as previously described [39,67,68].”
BackgroundResultSelf-citationOh, H.-S., Mammucari, C., Nenci, A., Cabodi, S., Cohen, S. N., & Dotto, G. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082123999 · Cited by 54 · cited 1×
“For example, WISp39 has been shown to stabilise the p21 protein [33]; whilst tumour susceptibility gene 101 (TSG101) enhances the cyclin/CDK inhibitory activity of p21 by stabilising the p21/cyclin/CDK complexes [33,34].”
BackgroundKatsel, P., Tan, W., Fam, P., Purohit, D. P., & Haroutunian, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068361 · Cited by 52 · cited 1×
“The finding is also consistent with recent findings of deficient p53-dependent DNA damage repair, which requires a fully functional p21 [59] in AD [73].”
ResultYoon, M., Venkatachalam, V., Huang, A., Choi, B., Stultz, C. M., & Chou, J. J. (2009) · Protein Science · doi:10.1002/pro.34 · Cited by 44 · cited 2×
“Whilst the p21 protein is an intrinsically unstructured protein [36], its preference for certain conformational arrangements will depend on the charges of its residues.”
BackgroundEvdokiou, A., Raggatt, L. J., Atkins, G. J., & Findlay, D. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.10.0359 · Cited by 42
p21 gene codon 31 polymorphism is associated with bladder cancer
Chen, W., Wu, H., Hsu, C.-D., Chen, H.-Y., & Tsai, F. (2002) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(01)00152-1 · Cited by 42
Lee, J. H., Cheng, R., Santana, V., Williamson, J., Lantigua, R., Medrano, M. A., Arriaga, A., Stern, Y., Tycko, B., Rogaeva, E. A., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1591 · Cited by 39
The dysregulation of the cell cycle and the diagnosis of Alzheimer's disease
Nagy, Z. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.11.001 · Cited by 37 · cited 4×
“In a preliminary study, the variant (present in ~7% of populations of European descent according to the Ensembl genome database) was found to be associated with an increased risk and reduced age of onset of AD [23].”
BackgroundResultInfluentialSelf-citationNaj, A., Jun, G., Buros, J., Gallins, P., Farrer, L., Haines, J., Pericak‐Vance, M., Schellenberg, G., & The Alzheimer's Disease Genetics Consortium (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.530 · Cited by 36
Gravina, S., Lescai, F., Hurteau, G. J., Brock, G., Saramäki, A., Salvioli, S., Franceschi, C., & Roninson, I. B. (2009) · Aging · doi:10.18632/aging.100041 · Cited by 35 · cited 1×
“All our findings were consistent with the known association of the p21 SNPs with cancer in populations of European descent [16–22]: the population group where the SNPs are the least prevalent [66].”
ResultDC11: a novel monoclonal antibody revealing Alzheimer’s disease-specific tau epitope
Vechterova, L., Kontseková, E., Žilka, N., Ferencĭk, M., Ravid, R., & Novák, M. (2003) · Neuroreport · doi:10.1097/00001756-200301200-00017 · Cited by 34
Bialopiotrowicz, E., Kuzniewska, B., Kachamakova-Trojanowska, N., Barcikowska, M., Kuznicki, J., & Wojda, U. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.017 · Cited by 32 · cited 1×
“On the other hand, the finding of p21 overexpression in peripheral lymphoblasts of AD patients does warrant further investigations into the role of the protein in the disease process [69,70].”
BackgroundAnalysis of DNA-general methods
Ormerod, M. G. (2000) · doi:10.1093/oso/9780199638253.003.0006 · Cited by 31
Relationship Between Genetic Risk Factors and Markers for Alzheimer’s Disease Pathology
Elias-Sonnenschein, L. S., Bertram, L., & Visser, P. J. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.56 · Cited by 29 · cited 1×
“A relatively recent review found that several other identified genetic risk factors for AD show no similar genotype-phenotype relationship [77] suggesting that these SNPs, whilst affecting AD susceptibility, do not have a direct effect on tau and amyloid accumulation.”
BackgroundHCaRGis a novel regulator of renal epithelial cell growth and differentiation causing G2M arrest
Devlin, A. M., Solban, N., Tremblay, S., Gutkowska, J., Schürch, W., Orlov, S. N., Lewanczuk, R. Z., Hamet, P., & Tremblay, J. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00252.2002 · Cited by 27
Liu, F., Li, B., Wei, Y., Chen, X., Ma, Y., Yan, L., & Wen, T. (2011) · Mutagenesis · doi:10.1093/mutage/ger010 · Cited by 27 · cited 3×
“The lack of association between these SNPs and cancer in other ethnic groups [20] may be due to other genetic and environmental factors that may either impact on the functional effects of the SNPs or affect the development of cancer.”
BackgroundEsteras, N., Alquézar, C., Bermejo-Pareja, F., Bialopiotrowicz, E., Wojda, U., & Martín-Requero, Á. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.014 · Cited by 25 · cited 1×
“On the other hand, the finding of p21 overexpression in peripheral lymphoblasts of AD patients does warrant further investigations into the role of the protein in the disease process [69,70].”
BackgroundAltered Processing of Amyloid Precursor Protein in Cells Undergoing Apoptosis
Fiorelli, T., Kirouac, L., & Padmanabhan, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057979 · Cited by 21 · cited 1×
“Alternatively, the complex relationship between DNA-damage-repair signalling, apoptosis and beta amyloid [74] may be dependent on other risk factors (genetic and environmental) that either have a stronger effect on betaamyloid accumulation than these SNPs or alter the effect of them.”
BackgroundIdentification of a novel calcitonin-response element in the promoter of the human p21WAF1/CIP1 gene
Evdokiou, A., Raggatt, L. J., Sakai, T., & Findlay, D. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250195 · Cited by 18
Ressiniotis, T., Griffiths, P. G., Keers, S. M., Chinnery, P. F., & Birch, M. (2005) · BMC Ophthalmology · doi:10.1186/1471-2415-5-5 · Cited by 18 · cited 1×
“The SNP at codon 31 of p21 induces an amino acid change in the zinc finger domain [20,35] that lies between a cyclin (amino acids: aa 17–24) and CDK binding sites (aa 53–58) [33].”
Background
Cited by
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“However, the evidence remains inconclusive, as a number of studies have reported increased levels in the brains of AD patients compared to controls [192,193], while others have found no significant differences [194].”
BackgroundCellular Senescence in Neurodegenerative Diseases
Martínez-Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 281
“The other abnormal protein found in AD brains is hyperphosphorylated tau in the form of NFTs, which have been reported to induce senescence (Mendelsohn and Larrick, 2018).”
BackgroundInfluentialAyeb‐Karlsson, S., Kniveton, D. R., Cannon, T., van der Geest, K., Ahmed, I., Derrington, E. M., Florano, E. R., & Opondo, D. O. (2019) · Disasters · doi:10.1111/disa.12404 · Cited by 97
Senescence: A DNA damage response and its role in aging and Neurodegenerative Diseases
Shreeya, T., Ansari, M. S., Kumar, P., Saifi, M., Shati, A. A., Alfaifi, M. Y., & Elbehairi, S. E. I. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1292053 · Cited by 83
DNA double-strand breaks: a potential therapeutic target for neurodegenerative diseases
Thadathil, N., Hori, R. T., Xiao, J., & Khan, M. M. (2019) · Chromosome Research · doi:10.1007/s10577-019-09617-x · Cited by 54
Metadata
- Authors
- Yates, S. C., Zafar, A., Rabai, E. M., Foxall, J. B., Nagy, S., Morrison, K. E., Clarke, C., Esiri, M. M., Christie, S., Smith, A. D., & Nagy, Z.
- Affiliations
- University of Birmingham (GB)
- John Radcliffe Hospital (GB)
- University of Oxford (GB)
- Corresponding author
- Nagy, Zsuzsanna
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-01-27
- Volume
- 10
- Issue
- 1
- Pages
- e0114050
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4308198
- OpenAlex
- W2091307037
- Cited by
- 31
- References
- 78
- Citations by year
- 2024: 2 · 2023: 4 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 2 · 2017: 3 · 2016: 5
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (Queen's University Belfast) (acceptedVersion, cc-by)
- ePrints Soton (University of Southampton) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- Sir Jules Thorn Charitable Trust
- University of Birmingham
- Medical Research Council (MR/L022656/1)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- p21, Alzheimer's disease, Parkinson's disease dementia, genetic polymorphism, cancer-associated variants, cell cycle inhibition, anti-apoptotic effects, neurofibrillary tangles, age of onset, neurodegeneration
- MeSH terms
- Alzheimer Disease, Cell Cycle, Gene Frequency, Humans, Temporal Lobe, tau Proteins, Apoptosis, Age of Onset, Disease-Free Survival, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, White People, Cyclin-Dependent Kinase Inhibitor p21, Kaplan-Meier Estimate, Genetic Association Studies, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.